ANGELALIGN (06699): Building Innovation Barriers with Intellectual Property Rights, Legal Compliance, and Supply Chain Optimization Safeguard Global Growth

On August 25th, the leading invisible orthodontics company, ANGELALIGN (06699), released its mid-term performance report for 2025, showing strong growth in several key indicators and expressing its strategic commitment to increasing long-term investments in multiple key areas. During the reporting period, the total number of invisible orthodontic cases of the company increased significantly by 47.7% year-on-year, reaching approximately 225,800 cases. The number of international market cases increased by 103.5% year-on-year, reaching about 117,200 cases, surpassing the 108,600 cases in the Chinese market, demonstrating significant effects of globalization. Driven by the rapid increase in the number of cases, combined with continuous optimization of medical design and intelligent manufacturing systems, the company achieved a revenue of $161 million in the first half of the year, a 33.1% year-on-year increase. The gross profit reached $101 million, and the adjusted net profit reached $19.5 million, showing a continuous improvement in overall operational quality. ANGELALIGN believes that with its efficient synergy of medical design and digital production platform, continuous product innovation, and expansion into overseas markets, the company demonstrates its core competitiveness and long-term growth resilience in the field of orthodontics. While achieving impressive performance, ANGELALIGN stated its intention to further increase investments in sales and marketing, clinical support, and customer service. The company will establish and operate the Xi'An International Medical Investment Design Center and manufacturing base, enhance legal capabilities to advance intellectual property strategies and compliance, and further upgrade data security infrastructure. The establishment of a knowledge property strategy around R&D and the construction of a global compliance system have been identified as core priorities for the company. As global business continues to expand, ANGELALIGN is systematically enhancing its legal capabilities at the strategic level, including expanding the legal team and adding corresponding resources, aiming to build a comprehensive system covering the creation, protection, and management of intellectual property rights, to provide solid compliance support and risk barriers for the company's international operations, and to empower the steady advancement of global market expansion and innovative business. Intellectual property is the institutional guarantee and core competitiveness of ANGELALIGN's research and development innovation. The company actively lays out a comprehensive patent portfolio in mainstream markets worldwide, including orthodontic device design, material technology, intelligent manufacturing, and diagnostic software. In the first half of 2025, the company not only launched innovative products such as the A10 Expansion Solution, AngelActivator HG, Angel Locking Bite Plate, and Angel Curved Plate, but also deeply integrated intelligent initial consultation and follow-up monitoring into the orthodontic process, all supported by a rigorous patent system. ANGELALIGN attaches great importance to patent layout during the research and development process, promoting the integration of clinical practice and digital technology innovation, ensuring that each new generation of products and technical solutions can form effective patent barriers. The core of intellectual property management lies not only in protecting its own innovations but also in fully complying with regulatory requirements in different regions worldwide. Therefore, ANGELALIGN regards "compliance" as another important pillar of its intellectual property strategy, implementing strict intellectual property compliance reviews throughout the product lifecycle to ensure that business expansion complies with local laws and regulations, thereby minimizing intellectual property risks in global operations. In addition to focusing on intellectual property, ANGELALIGN is also continuing to invest in the global supply chain and data security. To meet the growing demand in international markets, the company is accelerating the development of an environmentally friendly, highly scalable, world-class intelligent manufacturing system, and planning to establish or expand production and medical design centers in multiple regions. Currently, medical design centers in Brazil and Southeast Asia are operating successfully, providing support for the North American market, demonstrating significant efficiency in global resource coordination. In terms of data security and privacy protection, ANGELALIGN has invested heavily in upgrading IT infrastructure and operational processes, strictly complying with data protection regulations (such as GDPR, CCPA, etc.) in all operational regions, establishing a full lifecycle security management system from data collection, storage to processing. This investment is not only necessary for compliance but also the cornerstone of winning the trust of global users, doctors, and partners. Looking to the future, with its outstanding product innovation, efficient global supply chain system, and rigorous and comprehensive intellectual property layout, ANGELALIGN has steadily entered a new stage of high-quality growth. The company's strong resilience and strategic determination demonstrated in its internationalization process not only further solidify its leading position in the global invisible orthodontics field but also set a benchmark for innovation and compliance in the industry. Following the release of its performance report, ANGELALIGN's stock price surged strongly, exceeding 9% at one point, fully demonstrating the market's high recognition of its mid-term performance in 2025 and its firm confidence in the company's globalization strategy and sustainable growth capabilities. The global invisible orthodontic market is promising, and with the continued increase in international market share and the gradual realization of various strategic investments, ANGELALIGN is expected to further break through the growth ceiling and set sail for accelerated value enhancement.